Omeprazole | Preferred Pharmaceuticals Inc. Breastfeeding

It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Omeprazole | Preferred Pharmaceuticals Inc. is safe for baby while breastfed.

What is Omeprazole | Preferred Pharmaceuticals Inc. used for?


Omeprazole delayed-release capsules are a proton pump inhibitor (PPI) indicated for the: •Treatment of active duodenal ulcer in adults (1.1) •Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults (1.2) •Treatment of active benign gastric ulcer in adults (1.3) •Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 2 years of age and older (1.4) •Maintenance of healing of EE due to acid-mediated GERD in patients 2 years of age and older (1.6) •Pathologic hypersecretory conditions in adults (1.7) 1.1 Treatment of Active Duodenal Ulcer Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy. 1.2 Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence. Triple Therapy Omeprazole delayed-release capsules in combination with clarithromycin and amoxicillin, is indicated for treatment of patients with H. pylori infection and duodenal ulcer disease (active or up to 1-year history) to eradicate H. pylori in adults. Dual Therapy Omeprazole delayed-release capsules in combination with clarithromycin are indicated for treatment of patients with H. pylori infection and duodenal ulcer disease to eradicate H. pylori in adults. Among patients who fail therapy, omeprazole delayed-release capsules with clarithromycin is more likely to be associated with the development of clarithromycin resistance as compared with triple therapy. In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted [see Clinical Pharmacology (12.4) and the clarithromycin prescribing information, Microbiology section]. 1.3 Treatment of Active Benign Gastric Ulcer Omeprazole delayed-release capsules are indicated for short-term treatment (4 to 8 weeks) of active benign gastric ulcer in adults. 1.4 Treatment of Symptomatic Gastroesophageal Reflux Disease (GERD) Omeprazole delayed-release capsules are indicated for the treatment of heartburn and other symptoms associated with GERD for up to 4 weeks in patients 2 years of age and older. 1.5 Treatment of Erosive Esophagitis (EE) Due to Acid-Mediated GERD Pediatric Patients 2 Years of Age to Adults Omeprazole delayed-release capsules are indicated for the short-term treatment (4 to 8 weeks) of EE due to acid-mediated GERD that has been diagnosed by endoscopy in patients 2 years of age and older. The efficacy of omeprazole delayed-release capsules used for longer than 8 weeks in patients with EE has not been established. If a patient does not respond to 8 weeks of treatment, an additional 4 weeks of treatment may be given. If there is recurrence of EE or GERD symptoms (e.g., heartburn), additional 4 to 8 week courses of omeprazole delayed-release capsules may be considered. 1.6 Maintenance of Healing of EE Due to Acid-Mediated GERD Omeprazole delayed-release capsules are indicated for the maintenance healing of EE due to acid-mediated GERD in patients 2 years of age and older. Controlled studies do not extend beyond 12 months. 1.7 Pathological Hypersecretory Conditions Omeprazole delayed-release capsules are indicated for the long-term treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine adenomas and systemic mastocytosis) in adults.

I am currently breastfeeding and I want to know if using Omeprazole | Preferred Pharmaceuticals Inc. is safe for my kid? Does it have any effect on milk production?

Omeprazole | Preferred Pharmaceuticals Inc. safe for breastfeeding
Omeprazole is the only one ingredient used in manufacturing of Omeprazole | Preferred Pharmaceuticals Inc., Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Omeprazole it is safe to use Omeprazole | Preferred Pharmaceuticals Inc. while lactating. We suggest you to check further details below about Omeprazole usage in breastfeeding.

Omeprazole | Preferred Pharmaceuticals Inc. Breastfeeding Analsys


Omeprazole while Breastfeeding

Safe

CAS Number: 73590-58-6

High plasma protein binding makes excretion into breast milk to be insignificant. No side effects were observed in breastfed infants of treated mothers. Shown to be labile in acid-pH environment must be administered in the form of micro-granules within an enteric-coated capsule. Any small quantity reaching the infant's stomach would be readily inactivated. Hyperprolactinemia and Galactorrhea have been reported.


Omeprazole | Preferred Pharmaceuticals Inc. Breastfeeding Analsys - 2


Omeprazole while Breastfeeding

CAS Number: 73590-58-6

Limited information indicates that maternal omeprazole doses of 20 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants.


Omeprazole | Preferred Pharmaceuticals Inc. and breastfeeding

What should I do if already breastfed my kid after using Omeprazole | Preferred Pharmaceuticals Inc.?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Omeprazole | Preferred Pharmaceuticals Inc. and have used it then do not panic as Omeprazole | Preferred Pharmaceuticals Inc. is mostly safe in breastfeeding and should not cause any harm to your baby.


My health care provider has asked me to use Omeprazole | Preferred Pharmaceuticals Inc., what to do?

Definitely, Omeprazole | Preferred Pharmaceuticals Inc. is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Omeprazole | Preferred Pharmaceuticals Inc., will my baby need extra monitoring?

No extra baby monitoring required while mother is using Omeprazole | Preferred Pharmaceuticals Inc.


Who can I talk to if I have questions about usage of Omeprazole | Preferred Pharmaceuticals Inc. in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week